Albiglutide, a once-weekly formulation of a glucagon-like peptide-1 agonist, appears to be effective at controlling blood sugar compared with insulin, according to a release from GlaxoSmithKline.
eHealthcare Solutions (EHS) manages advertising on this website.
We use cookies to ensure that we give you the best experience on our website.
By continuing, you agree to the use of cookies as per the EHS Privacy Policy